Co-Authors
This is a "connection" page, showing publications co-authored by Miles Carroll and Laurent Humeau.
Connection Strength
0.523
-
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model. Vaccine. 2021 08 09; 39(34):4885-4894.
Score: 0.238
-
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. EClinicalMedicine. 2021 Jan; 31:100689.
Score: 0.230
-
Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020 05 20; 11(1):2601.
Score: 0.055